Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received a 65-day suspension order for its drug license from the Assistant Drugs Controller in Durg District, Chhattisgarh. The suspension affects a single store located in Santrabadi Durg. The order was received on May 5, 2026, citing violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company has disclosed a potential revenue loss of Rs 16 lakh due to this suspension.
The impact appears limited as this involves only one store out of Medplus's much larger pharmacy network. The Rs 16 lakh potential revenue loss is relatively small compared to the company's overall operations, though it highlights regulatory compliance risks in the pharmacy retail business.